Cargando…

Meta-analysis of the clinicopathological significance of miRNA-145 in breast cancer

Low expression of tumor suppressor microRNA (miRNA) and high expression of carcinogenic miRNA promote the occurrence and progression of human cancer. Most studies show that miR-145 is a tumor suppressor miRNA, and is closely related to the clinicopathology of breast cancer. However, the results are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Peng, Zhang, Zhenzhu, Hou, Li, Zhang, Yayue, Lu, Lingeng, Wang, Chong, Shi, Fengqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2020
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502658/ https://www.ncbi.nlm.nih.gov/pubmed/32869851 http://dx.doi.org/10.1042/BSR20193974

Ejemplares similares

Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival
por: Wang, Danyang, et al.
Publicado: (2021)

Expression and clinical significance of miRNA-145 and miRNA-218 in laryngeal cancer
por: Guo, Libing, et al.
Publicado: (2019)

MiRNA-423 rs6505162 and miRNA-6811 rs2292879 SNP associated with lung cancer in Hainan, China
por: Zhou, Jing, et al.
Publicado: (2023)

Expression of miRNA-206 and miRNA-145 in breast cancer and correlation with prognosis
por: Quan, Yan, et al.
Publicado: (2018)

Mitochondria-related core genes and TF-miRNA-hub mrDEGs network in breast cancer
por: Yan, Li-rong, et al.
Publicado: (2021)

Clinicopathological and prognostic significance of osteopontin expression in patients with prostate cancer: a systematic review and meta-analysis
por: Yu, Anze, et al.
Publicado: (2021)

No Significant Difference between Plasma miRNAs and Plasma-Derived Exosomal miRNAs from Healthy People
por: Tian, Fei, et al.
Publicado: (2017)

The correlation of circulating pro‐angiogenic miRNAs’ expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer
por: Peng, Wei, et al.
Publicado: (2018)

Tanshinone II A enhances pyroptosis and represses cell proliferation of HeLa cells by regulating miR-145/GSDMD signaling pathway
por: Tong, Wenjuan, et al.
Publicado: (2020)

MiR‐145 inhibits human colorectal cancer cell migration and invasion via PAK4‐dependent pathway
por: Sheng, Nengquan, et al.
Publicado: (2017)

An miRNA signature associated with tumor mutation burden in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020)

Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients
por: Hu, Maogui, et al.
Publicado: (2021)

Clinicopathological Significance of microRNA-31, -143 and -145 Expression in Colorectal Cancer
por: Wang, Chao-Jie, et al.
Publicado: (2009)

miRNA-145 inhibits VSMC proliferation by targeting CD40
por: Guo, Xin, et al.
Publicado: (2016)

LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis
por: Tian, Shubo, et al.
Publicado: (2020)

MiRNA-574-3p inhibits cell progression by directly targeting CCND2 in colorectal cancer
por: Li, Wen-Cui, et al.
Publicado: (2019)

Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis
por: Zhang, Jing, et al.
Publicado: (2020)

Genetic association analysis of miRNA SNPs implicates MIR145 in breast cancer susceptibility
por: Chacon-Cortes, Diego, et al.
Publicado: (2015)

A miRNAs panel promotes the proliferation and invasion of colorectal cancer cells by targeting GABBR1
por: Longqiu, Yang, et al.
Publicado: (2016)

MiR-940 promotes malignant progression of breast cancer by regulating FOXO3
por: Zhang, Huayao, et al.
Publicado: (2020)

Overexpression of Yes‐associated protein and its association with clinicopathological features of hepatocellular carcinoma: A meta‐analysis
por: Lin, Chengjie, et al.
Publicado: (2017)

Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations
por: Nishiyama, Naotaka, et al.
Publicado: (2011)

Downregulation of miRNA‐141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting
por: Li, Ping, et al.
Publicado: (2017)

Muscone suppresses gastric cancer via regulation of miRNA‐145
por: Gao, Feng, et al.
Publicado: (2021)

A five‐miRNA panel in plasma was identified for breast cancer diagnosis
por: Li, Minghui, et al.
Publicado: (2019)

Prognostic significance of the systemic immune‐inflammation index in pancreatic carcinoma patients: a meta-analysis
por: Li, Xiaocheng, et al.
Publicado: (2021)

Association of miRNA-145 with the occurrence and prognosis of hydrosalpinx-induced defective endometrial receptivity
por: Wang, Qingli, et al.
Publicado: (2021)

Prognostic significance of lncRNA DANCR expression in human cancers: a systematic review and meta-analysis
por: Liu, Wei, et al.
Publicado: (2021)

Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas
por: Kim, Sewha, et al.
Publicado: (2019)

Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis
por: Dai, Jian-bo, et al.
Publicado: (2020)

MiRNA-145 increases therapeutic sensibility to gemcitabine treatment of pancreatic adenocarcinoma cells
por: Lin, Yong, et al.
Publicado: (2016)

Defining fallopian tube‐derived miRNA cancer signatures
por: Dejene, Selam B., et al.
Publicado: (2019)

Prognostic significance of LncRNA GHET1 expression in various cancers: a systematic review and meta-analysis
por: Ye, Jing, et al.
Publicado: (2019)

MiR-942 regulates the function of breast cancer cell by targeting FOXA2
por: Zhang, Jinku, et al.
Publicado: (2019)

Clinicopathological characteristics and survival outcomes in pleomorphic lobular breast carcinoma of the breast: a SEER population‐based study
por: Yang, Li‐Peng, et al.
Publicado: (2017)

Prognostic value of miR-142 in solid tumors: a meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2021)

Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer
por: Coradduzza, Donatella, et al.
Publicado: (2022)

Lessons from miR-143/145: the importance of cell-type localization of miRNAs
por: Kent, Oliver A., et al.
Publicado: (2014)

Clinical value of integrated‐signature miRNAs in esophageal cancer
por: Zhang, Heng‐Chao, et al.
Publicado: (2017)

Evaluation of in vivo antitumor effects of low‐frequency ultrasound‐mediated miRNA‐133a microbubble delivery in breast cancer
por: Ji, Yanlei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9ed8vm5j1p7ip2psnglj8i399d